https://doi.org/10.1016/j.nano.2020.102345
E
Elias P. Rosen
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
77
Papers
1.4K
Citations
20
h-index
29
i10-index
Elias P. Rosen is an academic researcher from University of North Carolina at Chapel Hill. The author has contributed to research in topics: HIV Research and Treatment & HIV/AIDS Research and Interventions & HIV/AIDS drug development and treatment. The author has an h-index of 20, co-authored 66 publications.
ORCID: 0000-0001-5531-7281Papers by this author
worksPoly(2-oxazoline) nanoparticle delivery enhances the therapeutic potential of vismodegib for medulloblastoma by improving CNS pharmacokinetics and reducing systemic toxicity
2020 · Nanomedicine Nanotechnology Biology and Medicine · 55 citations
Impact of Dolutegravir Plus Lamivudine as First-line Antiretroviral Treatment on the Human Immunodeficiency Virus Type 1 Reservoir and Inflammatory Markers in Peripheral Blood
2024 · The Journal of Infectious Diseases · 11 citations
https://doi.org/10.1093/infdis/jiae530
Impact of Dolutegravir Plus Lamivudine as First-line Antiretroviral Treatment on the Human Immunodeficiency Virus Type 1 Reservoir and Inflammatory Markers in Peripheral Blood
2024 · The Journal of Infectious Diseases · 11 citations
https://doi.org/10.1093/infdis/jiae530
Examining the effects of the HIV‐1 protein Tat and morphine on antiretroviral accumulation and distribution within the brain
2024 · Clinical and Translational Science · 3 citations
https://doi.org/10.1111/cts.70035
A Cross-Biomeasure Study to Optimize Antiretroviral Adherence Estimation
2024 · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2 citations
https://doi.org/10.1097/qai.0000000000003570
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat